D-dimer Human ProcartaPlex™ Simplex Kit
Invitrogen™

D-dimer Human ProcartaPlex™ Simplex Kit

The Human D-dimer Simplex ProcartaPlex Kit measures D-dimer protein and is designed to be combinable with other Simplex kits so that you can create your own multiplex panel that utilizes Luminex xMAP technology for protein detection/quantitation.
Have Questions?
RéférenceQuantité
EPX01A-12149-90196 dosages
Référence EPX01A-12149-901
Prix (EUR)
268,73
Offre exceptionnelle en ligne
349,00
Économisez 80,27 (23%)
Each
Quantité:
96 dosages
Prix (EUR)
268,73
Offre exceptionnelle en ligne
349,00
Économisez 80,27 (23%)
Each
Le kit D-dimère humaine Simplex ProcartaPlex mesure la protéine D-dimère et est conçu pour être combiné à d’autres kits Simplex afin que vous puissiez créer votre propre panel multiplex qui utilise la technologie Luminex xMAP pour la détection/quantification des protéines. Lors de l’association de plusieurs kits Simplex (c.-à-d., lorsque vous n’utilisez pas de panneau multiplex préconfiguré), un seul kit de tampon (vendu séparément) est nécessaire pour chaque plaque de dosage, quelle que soit la taille du plex.

À propos des dosages ProcartaPlex pour la plateforme Luminex

Les immunodosages ProcartaPlex sont basés sur les principes du dosage ELISA sandwich, utilisant deux anticorps hautement spécifiques se liant à différents épitopes d’une protéine pour quantifier simultanément toutes les cibles protéiques à l’aide d’un instrument Luminex. Les dosages multiplex ProcartaPlex nécessitent seulement seulement 25 µl de plasma ou de sérum, ou 50 µl de surnageant de culture cellulaire, et seulement quatre heures pour obtenir les résultats analysés.

Plus de résultats par échantillon :mesure plusieurs cibles protéiques simultanément dans un seul échantillon de 25 à 50 µl

Technologie Luminex largement utilisée :plateforme de multiplexage hautement référencée pour la détection et la quantification des protéines

Les dosages ProcartaPlex utilisent la technologie Luminex xMAP (profilage multi-analytes) pour la détection et la quantification simultanées de 80 cibles protéiques maximum dans un échantillon unique de 25 à 50 µl provenant de plasma, de sérum, de surnageants de cultures cellulaires et d’autres liquides corporels.

Les microbilles Luminex dans le dosage ProcartaPlex sont colorées en interne avec des fluorophores rouges et infrarouges de proportions précises afin de créer des signatures spectrales spécifiques pouvant être identifiées par les systèmes de détection Luminex xMAP (p. ex., Luminex 200, FLEXMAP 3D et MAGPIX). Comme le dosage ELISA sandwich, le dosage ProcartaPlex utilise des paires d’anticorps appariées pour identifier la protéine d’intérêt. Dans un dosage multiplex, chaque microbille unique d’un point de vue spectral est marquée avec des anticorps spécifiques pour une protéine cible unique. Les protéines liées sont identifiées à l’aide d’anticorps biotinylés et de la streptavidine-R-phycoérythrine (RPE). La conjugaison d’anticorps spécifiques d'une protéine à une microbille distincte permet d’analyser plusieurs cibles dans un seul puits.

La différence la plus significative entre un dosage ProcartaPlex et un dosage ELISA est que l’anticorps de capture du dosage ProcartaPlex est conjugué à une microbille et n’est pas adsorbé par un des puits de la microplaque. Ainsi, les réactifs de dosage ProcartaPlex flottent librement dans la solution. Pour la détection, l’instrument Luminex 200, par exemple, contient deux lasers : un pour distinguer la signature spectrale de chaque microbille et un autre pour quantifier la quantité de fluorescence de la RPE. Cette dernière est proportionnelle à la quantité de protéine présente dans l’échantillon. Les dosages multiplex ProcartaPlex peuvent profiler plus de protéines cibles à l’aide d’un échantillon nettement moins important. Cela leur prend autant de temps que pour effectuer un dosage ELISA sandwich traditionnel.

Les panneaux multiplex ProcartaPlex sont disponibles en plusieurs formats et peuvent être utilisés sur six espèces (humain, souris, rat, primate non humain, porcin et canin). Rendez-vous sur le site thermofisher.com/procartaplex pour obtenir davantage d’informations. Vous y trouverez notamment une liste complète des cibles protéiques individuelles.

Usage exclusivement réservé à la recherche. Ne pas utiliser pour des procédures de diagnostic.

Spécifications
Plage de dosageAs determined for Lot 1: 317.99 - 1,302,500 pg/mL
Sensibilité du dosageVoir le certificat d’analyse
Type de microbillesD-dimère [44]
À utiliser avec (équipement)Instruments Luminex™
FormatKit simplex
ExpressionFibrinogen alpha chain
Alias de gèneFib2
Identification génétique (Entrez)2243
Symbole de gène(s)FGA
Gamme de produitsProcartaPlex
ProtéineFibrinogen alpha chain
Type d’échantillonSérum, plasma, surnageants de culture cellulaire (SCC), Plasma, Cell Culture Supernatants
Volume d’échantillonSérum, plasma : 25 μl, surnageant de culture cellulaire : 50 μlitres
Conditions d’expéditionWet Ice
ID UniProtP02671
CombinabilityCombinable
Type de produitKit simplex
Quantité96 dosages
Research AreaImmunology
EspècesHumaine
Unit SizeEach
Contenu et stockage
  • 1 flacon de microbilles de capture (50X)
  • 1 flacon d’anticorps de détection biotinylé (50X)
  • 2 flacons de mélange étalon humain D-Dimer (lyophilisé)
  • Conservez à 2–8°C.

Foire aux questions (FAQ)

What is the size of the Luminex beads you currently use?

The beads used in our Luminex instrument-compatible ProcartaPlex and QuantiGene Plex assays are 6.5 micron superparamagnetic beads.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

I am interested in performing Luminex assays using BioSource kits, and I have a Luminex xMAP system. Besides the kits and system, what other reagents and equipment will I need?

The following is a list of general lab supplies that are required for running BioSource immunoassays on the Luminex xMAP system:
1) Sonicating water bath
2) Orbital shaker
3) Vortexer
4) Repeating and/or multi-channel pipetter (not required, but recommended)
5) Calibrated adjustable precision pipettes, with disposable plastic tips
6) Glass/plastic tubes and racks for preparing reagents
7) Graduated cylinder and container for preparing wash solution
8) Aluminum foil
9) Deionized or distilled water.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Do the Luminex beads require special care in handling?

The Luminex beads should be protected from light because they are susceptible to photobleaching. We recommend protecting the beads by keeping containers covered with aluminum foil during all incubation steps, and exercising care during handling. The beads should not be frozen, subjected to excessive heat, or exposed to organic solvents.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Why would the Luminex acquisition software display "Sample Empty" messages during analysis?

(1) The user did not properly aliquot the diluted beads, such that no beads were actually added to the wells (make sure that the bead concentrates are sonicated and vortexed well, then check the pipet tip to ensure that air bubbles were not drawn up)
(2) The user missed loading diluted beads to some wells, which is likely since the small volume is clear and difficult to visualize in the clear plastic plate (we have now addressed this customer difficulty by coloring each of the Buffer Reagent Kit components)
(3) The user applied too much vacuum pressure at some point during the wash steps, or allowed the pressure to spike even once, such that the filter membrane tore in a few wells releasing the beads (make sure that the vacuum manifold pressure is kept below 5mm/in Hg, depending on their system -- a good rule of thumb is that it should take a full 3-second count to GENTLY empty the wells of 200uL)
(4) The user did not properly sonicate and vortex the beads prior to dilution, such that the percent of bead aggregation was high and the instrument was unable to find enough single beads to meet the events/bead value designated by the customer (make sure that the Bead Concentrate tube is put into the waterbath all the way to the cap, since the tube is hollow until the top third)
(5) The user lost beads by shaking the plate too aggressively or handling it improperly (make sure that the orbital shaker is set to a speed that allows for maximum vortex in the wells without spillage)
(6) The user exposed the beads to an excess of light during storage or running of the assay, such that some but not all of the beads were photobleached and therefore falling outside the acceptable range for each bead region (make sure that the plate is covered on the top/sides with foil throughout the assay, away from Windows and spotlights, and that the bead component of the kits is stored in the dark)*
(7) There was a clog in the sample needle, such that the instrument was unable to take up enough sample to meet the number of events requested per bead region (suggest that the user follow the manual instructions for dislodging a clog, which include several Back Flush steps and may require removal of the needle for sonication with probe alignment).

* Some of the older Antibody Bead Kits still have clear plastic tops instead of black ones. In cases where customers store kits in lit refrigerators, or keep them open on the lab bench, even a few hours of light exposure is enough to photobleach beads. It is important to note, in general, that higher number bead regions are more susceptible to photobleaching. In order to draw conclusions about the source of the difficulty, we would ask to see the data, specifically the Masterplex QT file, which would enable us to examine the pattern of "Sample Empty" occurrences in addition to the bead counts per well.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

What are the Luminex beads made of?

The beads are made of polystyrene.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Citations et références (5)

Citations et références
Abstract
Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls.
Authors:van den Dries L, Claassen MAA, Groothuismink ZMA, van Gorp E, Boonstra A
Journal:Virology
PubMed ID:28644978
'Sustained immune activation during chronic HIV infection is considered to augment co-morbidity and mortality. Effective combination antiretroviral therapy (cART) has shown to dampen immune activation especially during the first year cART, but the effects of long-term cART in patients without major comorbidities remains under-investigated. We performed a comprehensive analysis including ... More
The host response in critically ill sepsis patients on statin therapy: a prospective observational study.
Authors:Wiewel MA, Scicluna BP, van Vught LA, Hoogendijk AJ, Zwinderman AH, Lutter R, Horn J, Cremer OL, Bonten MJ, Schultz MJ, van der Poll T
Journal:Ann Intensive Care
PubMed ID:29349709
'Statins can exert pleiotropic anti-inflammatory, vascular protective and anticoagulant effects, which in theory could improve the dysregulated host response during sepsis. We aimed to determine the association between prior statin use and host response characteristics in critically ill patients with sepsis.' ... More
Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study.
Authors:Wiewel MA, Huson MA, van Vught LA, Hoogendijk AJ, Klein Klouwenberg PM, Horn J, Lutter R, Cremer OL, Schultz MJ, Bonten MJ, van der Poll T
Journal:Crit Care
PubMed ID:27719675
'Sepsis is a prominent reason for intensive care unit (ICU) admission in patients with HIV. We aimed to investigate the impact of HIV infection on presentation, outcome and host response in sepsis.' ... More
Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients.
Authors:van Vught LA, Scicluna BP, Hoogendijk AJ, Wiewel MA, Klein Klouwenberg PM, Cremer OL, Horn J, Nürnberg P, Bonten MM, Schultz MJ, van der Poll T
Journal:Crit Care
PubMed ID:27495247
Diabetes is associated with chronic inflammation and activation of the vascular endothelium and the coagulation system, which in a more acute manner are also observed in sepsis. Insulin and metformin exert immune modulatory effects. In this study, we aimed to determine the association of diabetes and preadmission insulin and metformin ... More
Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients.
Authors:Claushuis TA, van Vught LA, Scicluna BP, Wiewel MA, Klein Klouwenberg PM, Hoogendijk AJ, Ong DS, Cremer OL, Horn J, Franitza M, Toliat MR, Nürnberg P, Zwinderman AH, Bonten MJ, Schultz MJ, van der Poll T
Journal:Blood
PubMed ID:26956172
Preclinical studies have suggested that platelets influence the host response during sepsis. We sought to assess the association of admission thrombocytopenia with the presentation, outcome, and host response in patients with sepsis. Nine hundred thirty-one consecutive sepsis patients were stratified according to platelet counts (very low <50 × 10(9)/L, intermediate-low ... More